Has Nader Nassif, MD received payments from drug or device companies?

Yes. Drug and device makers reported $566,353 in general payments to Nader Nassif, MD across 316 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nader Nassif, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nader Nassif, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nader Nassif, MD

Adult Reconstructive Orthopaedic Surgery · Newport Beach, CANPI 1629262183

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.6%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 57.0% of the total. Reporting peaked in 2023 at $200,163 and has fallen 90.1% since, to $19,718 in 2025. Among adult reconstructive orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$566,353in general payments, 2019–2025

Across 316 payments — averaging $1792.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$323K
Medical Device Business Services, Inc.$242K
Johnson & Johnson$889
Zimmer Biomet$316
Smith+Nephew$248
Pacira Pharmaceuticals Incorporated$173

What the payments were for

Royalty or licence$200,00035%
Consulting fees$337,41760%
Travel & lodging$21,8124%
Food & beverage$7,1241%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	118	$322,613
Medical Device Business Services, Inc.	182	$242,114
Johnson & Johnson	9	$889
Zimmer Biomet	4	$316
Smith+Nephew	2	$248
Pacira Pharmaceuticals Incorporated	1	$173

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$566,353 in reported general payments places this provider in the 90th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$667,513

Medicare patients

1,109

Services billed

5,673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naloxone Hcl	19	$993
Meloxicam	210	$436
Amoxicillin	172	$291
Methocarbamol	46	$284
Tramadol Hcl	65	$246
Methylprednisolone	24	$190
Oxycodone Hcl	31	$153
Ondansetron Hcl	22	$106
Clindamycin Hcl	24	$82

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Newport Beach

James CaillouetteNewport Beach$4.8M
Matthew SiljanderNewport Beach$84K
William MaloneyStanford$11.1M
William LongLos Angeles$2.8M
John DearbornMenlo Park$2.5M
William Bugbeela Jolla$2.1M
James HuddlestonStanford$1.5M
Alexander SahFremont$1.2M
John DianaNapa$981K
Thomas DonaldsonColton$893K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →